title: Clinical considerations on Buruli ulcer employing two molecular tests for the detection of Mycobacterium ulcerans in 100 skin biopsies.
abstract: OBJECTIVE
  Buruli ulcer (BU) is an infected cutaneous lesion, the etiological agent of which is Mycobacterium ulcerans. Diagnosis is confirmed by the identification of acid-fast bacilli and culture. In clinically suspicious forms with negative bacteriological or Ziehl-Neelsen (ZN) findings, molecular tests are used. This study compared the concordance of nested polymerase chain reaction (PCR) (targeting IS2404) and PCR (targeting IS2606) in different clinical situations.
  
  
  METHODS
  A total of 57 samples were sourced from 39 BU patients. Control samples (n = 43) were obtained from non-BU ulcers in 38 patients. Samples were divided into two pieces and submitted to, respectively, histological examination and ZN staining, and PCR. Subsamples submitted to PCR were divided and submitted to nested PCR IS2404 and PCR IS2606, respectively.
  
  
  RESULTS
  Of the 57 BU biopsies, positive results were obtained by nested PCR in 18 (31.6%) and by IS2606 PCR in 37 (64.9%) cases. Sequencing of the positive samples confirmed the specificity of amplicons in all nested PCR samples and in 26 of 37 (70.2%) samples positive to IS2606. Hence, nested PCR was more specific (100% vs. 93%) and less sensitive (32% vs. 46%) than IS2606 PCR. In the BU samples, nested PCR was negative in 15 instances, and IS2606 PCR was negative in 11 instances in which ZN histology had been positive (false negatives). Both PCRs were positive in six ZN-negative smears.
  
  
  CONCLUSIONS
  We considered 57 samples from 39 BU patients in various clinical stages and at different times after the beginning of therapy. These provided positive results in 18 cases with IS2404 nested PCR and in 37 cases with PCR IS2606; only 26 of the latter remained positive subsequent to sequencing. Hence, even if IS2404 PCR is considered more specific, in subjects who appear to fail to respond to therapy, it is advisable to also carry out IS2606 PCR. A possible interpretation of the discordance between the two techniques due to unavoidable technical errors as well as to different sensitivity of the two tests at M. ulcerans DNA low concentration (i.e. in recent infection and in well-treated cases) is discussed.
authors: Dermatology Unit, Department of Translational Medicine, University of Piemonte Orientale Amedeo Avogadro, Novara, Italy.
authors: Giorgio
authors: G
authors: Leigheb
authors: Elisa
authors: E
authors: Zavattaro
authors: Paola
authors: P
authors: Molicotti
authors: Sara
authors: S
authors: Cannas
authors: Stephania
authors: S
authors: Zanetti
authors: Claudio
authors: C
authors: Clemente
authors: Roch C
authors: RC
authors: Johnson
authors: Ghislain E
authors: GE
authors: Sopoh
authors: Ange D
authors: AD
authors: Dossou
authors: Enrico
authors: E
authors: Colombo
mesh_terms: D001706:Biopsy; D054312:Buruli Ulcer / Q000382:microbiology* / Q000473:pathology; D016022:Case-Control Studies; D004396:Coloring Agents; D004269:DNA, Bacterial / Q000032:analysis*; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D008297:Male; D019911:Mycobacterium ulcerans / Q000235:genetics / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D012867:Skin / Q000473:pathology; D013194:Staining and Labeling
chemical_list: D004396:Coloring Agents; D004269:DNA, Bacterial